Predicting hematoma expansion after primary intracerebral hemorrhage - Wikidata - wikimedia - TriplyDB

Predicting hematoma expansion after primary intracerebral hemorrhage

Predicting hematoma expansion after primary intracerebral hemorrhage

http://www.wikidata.org/entity/Q34040461

about

Prediction and observation of post-admission hematoma expansion in patients with intracerebral hemorrhage.The critical care management of spontaneous intracranial hemorrhage: a contemporary review Intracerebral Hemorrhage: Perihemorrhagic Edema and Secondary Hematoma Expansion: From Bench Work to Ongoing Controversies Diagnosis and Management of Acute Intracerebral Hemorrhage.Which emphasizing factors are most predictive of hematoma expansion in spot sign positive intracerebral hemorrhage?The accuracy of spot sign in predicting hematoma expansion after intracerebral hemorrhage: a systematic review and meta-analysis.Intraventricular hemorrhage expansion in patients with spontaneous intracerebral hemorrhage Predicting Intracerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan Time Computed tomography angiography spot sign predicts intraprocedural aneurysm rupture in subarachnoid hemorrhage.Cutting delays in reversing anticoagulation after intracerebral haemorrhage: three key changes at a UK comprehensive stroke centre.Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective Study Timing of Occurrence Is the Most Important Characteristic of Spot Sign.Intracerebral Hemorrhage Outcomes in Patients with Systemic Cancer.Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion.Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.Antithrombotic treatment and intracerebral haemorrhage: between Scylla and Charybdis.The Pathophysiology of Intracerebral Hemorrhage Formation and Expansion.Phantom-based standardization of CT angiography images for spot sign detection.Association of Key Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease With Hematoma Volume and Expansion in Patients With Lobar and Deep Intracerebral Hemorrhage.Effect of CTA Tube Current on Spot Sign Detection and Accuracy for Prediction of Intracerebral Hemorrhage Expansion.Noncontrast Computed Tomography Markers of Intracerebral Hemorrhage Expansion.Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis.Association Between Hypodensities Detected by Computed Tomography and Hematoma Expansion in Patients With Intracerebral Hemorrhage.Small intracerebral hemorrhages have a low spot sign prevalence and are less likely to expand.Timing of INR reversal using fresh-frozen plasma in warfarin-associated intracerebral hemorrhage.The HEP Score: A Nomogram-Derived Hematoma Expansion Prediction Scale.Post-operative re-bleeding in patients with hypertensive ICH is closely associated with the CT blend sign.Prediction of intracerebral haemorrhage expansion with clinical, laboratory, pharmacologic, and noncontrast radiographic variables.Predictive Value of CTA Spot Sign on Hematoma Expansion in Intracerebral Hemorrhage Patients.Blend sign predicts poor outcome in patients with intracerebral hemorrhage.Leukocyte Count and Intracerebral Hemorrhage Expansion.CT Angiography Spot Sign, Hematoma Expansion, and Outcome in Primary Pontine Intracerebral Hemorrhage.Association Between Serum Calcium Level and Extent of Bleeding in Patients With Intracerebral Hemorrhage.Predictors of hematoma expansion predictors after intracerebral hemorrhage.Extravasation of contrast (Spot Sign) predicts in-hospital mortality in ruptured arteriovenous malformation.Increased Expression of Mitochondrial Inner-Membrane Protein Mpv17 After Intracerebral Hemorrhage in Adult Rats.Ultra-early hematoma growth in antithrombotic pretreated patients with intracerebral hemorrhage.Factors Associated with the Need for Intensive Care Unit Admission Following Supratentorial Intracerebral Hemorrhage: The Triage ICH Model.Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.

P2860

Q27008354-C829FBC1-19C5-4162-83B4-3B219B8AEEC1 Q28067962-88221F61-3DB0-4FDF-9470-6B07D994696E Q28073307-E2E6B52F-DBAC-43D1-A4C2-F683FB9B5D02 Q31136660-D8755F29-2B80-4BBB-B668-FD31721764B6 Q34356367-2224B5E2-7CEE-426F-9DF9-4F172D1E5306 Q34776423-677AB9B1-44C9-444B-9DE1-FAB911786254 Q35154916-38C1EA39-75D6-4A09-BF03-CE6ECC5822E1 Q35914886-1F77A8AB-BD17-4C6A-AA8A-40E3336AD725 Q36262082-43DA0571-4240-4968-8289-FEB31AF1F7DD Q36281975-6C12C333-2DBA-4EE8-8F1E-5E4B30A8F759 Q36302446-7CBB3785-81FD-4E1C-937C-C11226DBD8D3 Q36838308-82635653-5F23-4B2B-9C03-D4B366640B7E Q36839924-9EEC1103-E248-47FE-B953-5EBE9D6F768A Q37691179-E945A570-451D-4BAA-BA0A-BD5D96F4A1A6 Q38374087-206452C7-4A4E-48F7-9331-3D75C3F2353E Q38375358-FC98D3EE-11BA-4F28-BA8F-DF3B57A661F1 Q38448388-08B386F1-86BB-484F-9377-28C2D50C6BCE Q38527557-F69C39E7-C8F9-420C-8360-22BC70CD3745 Q38668827-137B62BF-F8F3-40EE-B239-FA4C3F082A50 Q38813005-0E30D1A2-20D6-4D8B-939E-0944015BA9A7 Q38865071-5FCEC339-5291-4AEC-A22E-4E2F1802A3A5 Q39176601-AFD3CBE6-AE71-4154-A35B-7297C857605E Q39228058-61A476D0-A7B2-41E7-B7CE-086E265122EC Q39669954-A299C6D7-5046-4D73-9D62-29B45DB443EA Q40090628-32B10F62-BB5C-492F-83F0-94ED59EA4740 Q40475411-6C1665BD-9D51-494B-A4C8-0D8E94C0D5FE Q40950987-8AE2FE2B-4DFA-4350-AEDF-B9142A30C717 Q40956676-A0DE96FA-E998-49CC-8224-44DED3E3E941 Q41005980-F1516F5A-2749-4533-B363-A649ED1E1392 Q41491305-82B77A9A-54BB-4A82-9632-E96D7AD6597A Q41501495-DDD60EFC-13F7-4386-9C7A-F90EC18DF0DB Q41851667-844B564B-339E-4CF4-BA84-F241A6394447 Q42426171-30CB1C74-664A-4F80-964A-9EB122AA0019 Q43097548-793922CD-6F12-4973-95B2-9AFCBAA8E40E Q46191310-152439FA-F036-4E99-80F9-F8A45C0E356C Q47843362-6F67AB2C-53B9-446E-B896-9EE1295667CB Q48102691-BF02D854-C575-461F-9DA5-5F6A73B20292 Q48346851-5DEEC3F6-BFDF-422F-9342-B8691DD23AF3 Q50985909-551624C1-68A6-42AF-B1FF-47192F667A83 Q55395487-3DCE81A9-85A8-4F68-BCE1-6DAAF0804B93

P2860

Predicting hematoma expansion after primary intracerebral hemorrhage

http://www.wikidata.org/entity/Q34040461

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Predicting hematoma expansion after primary intracerebral hemorrhage

@ast

Predicting hematoma expansion after primary intracerebral hemorrhage

@en

Predicting hematoma expansion after primary intracerebral hemorrhage

@nl

type

label

Predicting hematoma expansion after primary intracerebral hemorrhage

@ast

Predicting hematoma expansion after primary intracerebral hemorrhage

@en

Predicting hematoma expansion after primary intracerebral hemorrhage

@nl

prefLabel

Predicting hematoma expansion after primary intracerebral hemorrhage

@ast

Predicting hematoma expansion after primary intracerebral hemorrhage

@en

Predicting hematoma expansion after primary intracerebral hemorrhage

@nl

P1433

Q34040461-BBC0EC43-41C5-4745-A172-8B27C5D05C91

P1476

Q34040461-91729E0E-0C29-4FA2-8978-0A110492ED8E

P2093

Q34040461-0B15BC10-2334-4775-A176-95082B20F419

Q34040461-0CFF3F43-37EA-4D0D-BA73-F064B46E64C9

Q34040461-16F6D4E8-AF7E-487E-98D0-F14985670AD0

Q34040461-28A2E7FD-4EC1-4300-AAF4-97EDD9D51BBC

Q34040461-3F73CF49-CC2B-4ECF-865F-B3CE5D5118F2

Q34040461-5F99B00C-C81B-4EAC-B39D-74F81E141F64

Q34040461-661608AE-BA1C-417E-8A5A-1C9652FAE2F8

Q34040461-7C3BA04F-BA85-43C9-8289-E2D708E93387

Q34040461-94701146-8361-4530-8C80-8E03C1A2E067

Q34040461-94841909-C28C-440B-BCEF-DAEFD96B374B

P2860

Q34040461-00AF64EA-3647-4730-9CE2-57060DCF1806

Q34040461-027D38DB-032D-45C4-8981-3EB857173143

Q34040461-02E98E2B-70CE-4A1C-8B7C-61C8105E05C3

Q34040461-0F0F527F-BE02-4BFF-9288-DDE4D05D88F0

Q34040461-1444D82E-BC24-426C-AA9E-E6A67E73241E

Q34040461-16F8F364-F2F8-424B-A8F8-5532DD4873D3

Q34040461-2B23E3BE-C1CF-4A33-94EA-A5C02B462E8E

Q34040461-39DC8393-70F0-4FE1-900D-BAFF23F749F5

Q34040461-3C65B71E-567E-4499-AE5A-E16DB5071A03

Q34040461-4487B074-B9D5-4F3E-B1A6-DECB58DEC203

P304

Q34040461-22622011-CA5F-4C31-A534-010B574C263E

P31

Q34040461-57E4C206-F388-4E88-A68F-B17400AC3C89

P356

Q34040461-E3364FB5-4E58-45D5-A4D7-3425AA4E12C8

P407

Q34040461-170BC6E6-E447-41F7-AE6C-2342861C389C

P433

Q34040461-05875A1A-3A69-4450-A2EC-2788C410EE84

P478

Q34040461-9EDA329F-6F93-4CC8-BBF8-F263D2E5DAAB

P50

Q34040461-9B0B90FC-918C-40E8-BB18-ECF6A4188436

P577

Q34040461-ACBB711B-B91C-48FB-9371-7E63196AEC4D

P5875

Q34040461-7D89E4BB-5C04-4C17-A573-5333B7E2B032

P698

Q34040461-0EC72F3A-2689-4978-8749-18BD0DF0FACA

P932

Q34040461-E81995F1-2CBA-4890-BE53-88A24E1F02DA

P356

JAMANEUROL.2013.5433

P1433

P1476

Predicting hematoma expansion after primary intracerebral hemorrhage

@en

P2093

Alison M Ayres

http://www.w3.org/2001/XMLSchema#string

Anand Viswanathan

http://www.w3.org/2001/XMLSchema#string

Anastasia Vashkevich

http://www.w3.org/2001/XMLSchema#string

Guido J Falcone

http://www.w3.org/2001/XMLSchema#string

H Bart Brouwers

http://www.w3.org/2001/XMLSchema#string

Javier M Romero

http://www.w3.org/2001/XMLSchema#string

Joshua N Goldstein

http://www.w3.org/2001/XMLSchema#string

Kristen A McNamara

http://www.w3.org/2001/XMLSchema#string

Kristin Schwab

http://www.w3.org/2001/XMLSchema#string

Linda M Bresette

http://www.w3.org/2001/XMLSchema#string

P2860

Modeling intracerebral hemorrhage growth and response to anticoagulation

Intracerebral haemorrhage

Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes

Small intracerebral haemorrhages are associated with less haematoma expansion and better outcomes.

The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors.

Recombinant activated factor VII for acute intracerebral hemorrhage.

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.

Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.

Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage.

Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score.

P304

158-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMANEUROL.2013.5433

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan Rosand

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259455581

http://www.w3.org/2001/XMLSchema#string

P698

24366060

http://www.w3.org/2001/XMLSchema#string

P932

4131760

http://www.w3.org/2001/XMLSchema#string